Discover the Future with ProTom International

ProTom International Holding Corporation (“ProTom”, “Company” or “PIHC”) is a provider of cost-effective, commercially viable proton therapy systems. Because ProTom has lowered the risk to investors, through achieving full U.S. FDA 510 (k) clearance for our installations, prestigious initial site installations, ability to service debt via long-term service contracts, viable revenue pathways and building an experienced development and implementation team, we are poised to grow exponentially.